Sustainable diabetes care services during COVID-19 pandemic

被引:36
作者
Alromaihi, Dalal [1 ,2 ,3 ]
Alamuddin, Naji [1 ,2 ,3 ]
George, Suby [1 ]
机构
[1] King Hamad Univ Hosp, Al Sayh, Bahrain
[2] Med Univ Bahrain, Royal Coll Surg Ireland, Busaiteen, Bahrain
[3] Bahrain Diabet Soc, Al Sayh, Bahrain
关键词
Diabetes; Telemedicine; COVID-19; Electronic health record; Diabetes care; Teleconsultation; TELEMEDICINE;
D O I
10.1016/j.diabres.2020.108298
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The COVID-19 pandemic creates a challenge in the provision of care for patients with diabetes. Furthermore, those with uncontrolled diabetes are at a higher risk for complications due to COVID-19. The purpose of this study is to find an innovative method to sustain effective diabetes care services amidst the COVID-19 pandemic. Methods: Outpatient diabetes care was successfully transformed from traditional face-to-face encounters in the clinic to an online telemedicine service. Results: 1,972 patients were encountered over a 4-week study period during which we had a low proportion of unreached patients (4%). Some patients were still seen in person because they came as walk-in visits or insisted to be seen in person. Conclusion: Telemedicine has become an essential healthcare service and could be augmented by the use of technology like web-based applications and communication via transfer of data from patients' glucometer, insulin pumps, or sensors. Diabetes care can be transitioned to telemedicine effectively and would be successful in reaching more patients than by traditional face-to-face visits. This model of care is time consuming and unfortunately does not reduce the need for medical staff. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:4
相关论文
共 19 条
[1]  
[Anonymous], 2019, IDF DIABETES ATLAS, V9th
[2]   Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review [J].
Avidor, Daniel ;
Loewenstein, Anat ;
Waisbourd, Michael ;
Nutman, Amir .
COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2020, 18 (01)
[3]   A Literature Review of Email-based Telemedicine [J].
Caffery, Liam J. ;
Smith, Anthony C. .
GLOBAL TELEHEALTH, 2010, 161 :20-34
[4]   Telemedicine and type 1 diabetes: Is technology per se sufficient to improve glycaemic control? [J].
Franc, S. ;
Borot, S. ;
Ronsin, O. ;
Quesada, J-L. ;
Dardari, D. ;
Fagour, C. ;
Renard, E. ;
Leguerrier, A. -M. ;
Vigeral, C. ;
Moreau, F. ;
Winiszewski, P. ;
Vambergue, A. ;
Mosnier-Pudar, H. ;
Kessler, L. ;
Reffet, S. ;
Guerci, B. ;
Millot, L. ;
Halimi, S. ;
Thivolet, C. ;
Benhamou, P. -Y. ;
Penfornis, A. ;
Charpentier, G. ;
Hanaire, H. .
DIABETES & METABOLISM, 2014, 40 (01) :61-66
[5]   Telemedicine and diabetes: Achievements and prospects [J].
Franc, S. ;
Daoudi, A. ;
Mounier, S. ;
Boucherie, B. ;
Dardari, D. ;
Laroye, H. ;
Neraud, B. ;
Requeda, E. ;
Canipel, L. ;
Charpentier, G. .
DIABETES & METABOLISM, 2011, 37 (06) :463-476
[6]   Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities [J].
Garg, Satish K. ;
Rodbard, David ;
Hirsch, Irl B. ;
Forlenza, Gregory P. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (06) :431-439
[7]  
Home P, 2020, DIABETES METAB SYND, V14, P417, DOI 10.1016/j.dsx.2020.04.002
[8]   DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial [J].
Jeandidier, Nathalie ;
Chaillous, Lucy ;
Franc, Sylvia ;
Benhamou, Pierre-Yves ;
Schaepelynck, Pauline ;
Hanaire, Helene ;
Catargi, Bogdan ;
Farret, Anne ;
Fontaine, Pierre ;
Guerci, Bruno ;
Reznik, Yves ;
Penfornis, Alfred ;
Borot, Sophie ;
Serusclat, Pierre ;
Kherbachi, Yacine ;
D'Orsay, Genevieve ;
Detournay, Bruno ;
Simon, Pierre ;
Charpentier, Guillaume .
JMIR RESEARCH PROTOCOLS, 2018, 7 (04)
[9]  
Joubert Michael, 2019, J Diabetes Sci Technol, V13, P1161, DOI 10.1177/1932296819834054
[10]   Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity [J].
Klonoff, David C. ;
Umpierrez, Guillermo E. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 108